PROSTATE CANCER SYMPOSIUM

SATURDAY, APRIL 2, 2011 - 7:30 A.M. – 9:00 A.M.

 Morehouse School of Medicine  -  720 Westview Drive Southwest, Atlanta, GA 30310

PROGRAM OBJECTIVE:

                At the conclusion of this conference, participants should be able to:

1.  Identify patients at risk for prostate cancer and review potential benefit of   screening  and diagnosis of these patients. 

2.  Relate guidance to patients regarding primary treatments for prostate  cancer, including primary outcomes and quality of life considerations.

ACCREDITATION:

Morehouse School of Medicine is accredited by the Accreditation Council of Continuing Medical Education to sponsor Continuing Medical Education for physicians.

DESIGNATION OF HOURS:

The Morehouse School of Medicine designates the educational activity for a maximum of 2.0 hours in AMA PRA category 1 credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity. There should be no other reference to the CME sponsorship.

PROGRAM: - “PROSTATE CANCER TRENDS AND TRIALS”

Registration and Breakfast                                                                                                                                7:00 A.M.

Moderator                                                                                                                                                            7:30 A.M.

                Roland Mathews, M.D., Vice Chair Gynecologic Oncologist- Morehouse School of Medicine

Public Health Trends and Informed Decision Making for Prostate Cancer

                Tom Richards, M.D., Medical Officer, Division of Cancer Prevention and Control – CDC

Latest in Prostate Cancer Developments

                Frank Critz, M.D., Director of Prostate Cancer Research – RC Cancer Centers

Health Policy Impact on Prostate Cancer

                Jonathan Simons, M.D., President and CEO - Prostate Cancer Foundation

Disclosure

ACCME requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real and apparent conflict of interests: they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MSM for fair balance scientific, objectivity of studies mentioned in the materials or used as the basis for content, and the appropriateness of the patient care recommendations.

Registration and Conference Cost

All registrations and payments must be made prior to March 29, 2011. Cost for conference is $31.50 which includes administrative fees, attendee certificate and handling fees processed through the MSM office of CME.

For more information contact Mike 770-784-6938 mikekrachon@crbard.com OR

Shelly 770-682-2099 x 119 sglenn@rccancercenters.com

Parking Infromation: Lee Street will be closed for resurfacing. Please look out and follow Prostate Cancer Symposium directionals.